CDCP1 and lung carcinoma: Based on two independent cell‐based screening DELFIA assays, which showed no effect on cell viability at 6.25 μm, 8PN was identified as the top candidate to suppress CDCP1 levels on the surface of lung cancer cells (Fig. 1B).